Condition: Pancreatic Adenocarcinoma Metastatic · Pancreatic Ductal Adenocarcinoma · Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
The purpose of this clinical trial is to assess the safety and tolerability of TTFields in combination with chemotherapy in adults with metastatic pancreatic adenocarcinoma based on treatment-emergent adverse events of chemotherapy (modFOLFIRINOX) or device (TTFields). The main questions it aims to answer are: * Is TTFields treatment safe for the patients in combination with modFOLFIRINOX? * Are participants compliant with the treatment? * Is Is TTFields treatment effective in combination with modFOLFIRINOX against metastatic pancreatic adenocarcinoma?
This description comes directly from the study's public registry record.
Mariano Ponz Sarvisé, MD, PhD · +34 948255400 · mponz@unav.es
Lucía Ceniceros · +34 948255400 · lceniceros@unav.es
Always discuss trial participation with your own doctor first.
| Clínica Universidad de Navarra | Pamplona, Navarre, Spain | Recruiting |
| Hospital Universitario de Cruces | Barakaldo, Vizcaya, Spain | Not Yet Recruiting |
| Hospital de Galdakao | Galdakao, Vizcaya, Spain | Not Yet Recruiting |
| Fundación Jiménez-Díaz | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario de Araba | Vitoria-Gasteiz, Álava, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07284277